Success Metrics

Clinical Success Rate
57.1%

Based on 4 completed trials

Completion Rate
57%(4/7)
Active Trials
1(9%)
Results Posted
175%(7 trials)
Terminated
3(27%)

Phase Distribution

Ph not_applicable
10
91%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(4)
Terminated(3)
Other(3)

Detailed Status

Completed4
unknown3
Terminated3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
57.1%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (9.1%)
N/A10 (90.9%)

Trials by Status

unknown327%
completed436%
recruiting19%
terminated327%

Recent Activity

1 active trials
Showing 5 of 11
recruitingphase_1

Regenn® Therapy System Safety Study

NCT06259409
terminatednot_applicable

The Use of the Prevena Incision Management System (PIMS) on Closed Incisions in Renal Transplant Subjects

NCT01341444
terminatednot_applicable

The Use of PrevenaTM on Clean Closed Sternal Midline Incisions in Subjects at High Risk for Surgical Site Occurrences.

NCT02195310
unknownnot_applicable

Closed Incisional Negative Pressure Wound Therapy in Post-surgical Wound Care of Patients With Periprosthetic Joint Infection

NCT05357287
unknownnot_applicable

Application of PREVENA in Reducing Surgical Site Complications Following Reversal of Ileostomy or Colostomy

NCT04974931
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06259409Phase 1

Regenn® Therapy System Safety Study

Recruiting
NCT01341444Not Applicable

The Use of the Prevena Incision Management System (PIMS) on Closed Incisions in Renal Transplant Subjects

Terminated
NCT02195310Not Applicable

The Use of PrevenaTM on Clean Closed Sternal Midline Incisions in Subjects at High Risk for Surgical Site Occurrences.

Terminated
NCT05357287Not Applicable

Closed Incisional Negative Pressure Wound Therapy in Post-surgical Wound Care of Patients With Periprosthetic Joint Infection

Unknown
NCT04974931Not Applicable

Application of PREVENA in Reducing Surgical Site Complications Following Reversal of Ileostomy or Colostomy

Unknown
NCT02836990Not Applicable

Prevena™ vs Dermabond in Groin Wound Infections in Vascular Surgery

Completed
NCT02309944Not Applicable

Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients

Completed
NCT02020018Not Applicable

Negative Pressure Wound Therapy for Prevention of Poststernotomy Infection

Completed
NCT02389023Not Applicable

Comparison of Prevena Negative Pressure Incision Management System vs. Standard Dressing After Vascular Surgery

Unknown
NCT01854138Not Applicable

Evaluating Advantages of Prevena After Hip and Knee Arthroplasty

Completed
NCT02399111Not Applicable

A Trial to Evaluate Negative Pressure Incision Management System for Groin Wounds in Vascular Surgery Patients

Terminated

All 11 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
11